Meeting details menu

Meeting Authors
Meeting Abstracts
Keynote lectures
Oral communications
Poster presentations
Special symposia
Other

Acta Physiologica Congress

Back

Acta Physiologica 2011; Volume 201, Supplement 682
The 90th Annual Meeting of The German Physiological Society
3/26/2011-3/29/2011
Regensburg, Germany


THE CA2+-ACTIVATED POTASSIUM CHANNEL KCA3.1 SHOWS INCREASED EXPRESSION IN A549 LUNG CARCINOMA CELLS WITH HIGH METASTATIC POTENTIAL
Abstract number: P247

*Bulk1 E., Jungen2 D., Hascher2 A., Muller-Tidow2 C., Schwab1 A.

Lung cancer is one of the leading causes of death in the western world and is accompanied by the early development of metastasis. The ability of tumor cells to migrate is of great importance for the metastatic process. In addition to cytoskeletal mechanisms several members of Ca2+-activated K+ channels, and in particular KCa3.1, have been shown to be involved in cell migration. Here, we compared two strains of the lung carcinoma cell line A549 with low and high metastatic potential. The class comparison analysis of microarray expression data revealed significantly increased expression of the Ca2+-activated potassium channel KCa3.1 in the highly metastatic A549 cell line. This result could be validated on the mRNA level using PCR or quantitative real-time PCR. In migration experiments, trans-well assays showed that the highly metastatic A549 cell line exhibited an increased migratory activity towards a higher serum concentration than the parental cell line with low metastatic potential. Migration of the A549 cells could be stimulated by epidermal growth factor (EGF) and was more efficient when using a collagen-based matrix, composed of collagen type I, III and IV as well as laminin and fibronectin. Moreover, we could observe an increase of migratory activity in the highly metastatic A549 cell line when using the KCa3.1 channel activator 1-ethyl-2-benzimidazolinone (1-EBIO). In conclusion, these results provide evidence that the the Ca2+-activated potassium channel KCa3.1 might be involved in the metastatic process.

To cite this abstract, please use the following information:
Acta Physiologica 2011; Volume 201, Supplement 682 :P247

Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.

By continuing to browse this site you agree to us using cookies as described in our standard cookie policy .

CLOSE